CRL(Charles River Laboratories International, Inc.) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-25 | FY 截至 2022-12-31 | FY 截至 2023-12-30 | FY 截至 2024-12-28 | FY 截至 2025-12-27 |
|---|---|---|---|---|---|
| 营业收入 | $3.54B | $3.98B | $4.13B | $4.05B | $4.02B |
| 毛利润 | — | — | — | — | — |
| 营业利润 | $589.86M | $650.98M | $617.26M | $227.35M | $25.16M |
| 净利润 | $390.98M | $486.23M | $474.62M | $22.20M | −$144.34M |
| 经营现金流 | $760.80M | $619.64M | $683.90M | $734.58M | $737.65M |
| 自由现金流 | $532.03M | $294.91M | $365.37M | $501.61M | $518.49M |
| 摊薄每股收益 | $7.60 | $9.48 | $9.22 | $0.20 | $-2.91 |